Acrospire Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-9,931	Closed	-$137K	–	2368
2016 Q4	$137K	Sell	9,931 -1,164	-10%	-$16.1K	0.06%	682
2016 Q3	$200K	Sell	11,095 -2,700	-20%	-$48.7K	0.13%	160
2016 Q2	$198K	Sell	13,795 -3,888	-22%	-$55.8K	0.15%	86
2016 Q1	$211K	Buy	+17,683	New	+$211K	0.15%	179